Unchained Labs likes it hot, launches new isothermal applications on Uncle!

July 12, 2022 – Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tool for the job, launched new isothermal applications for biologics and gene therapies on its Uncle platform today. Uncle is the gold standard for measuring protein and AAV stability and with these new applications,... Read more

Bio-Techne Launches New Turbo CE-SDS Cartridge, Accelerating Protein Purity Analysis Throughput by 400%

MINNEAPOLIS, July 12, 2022 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced that ProteinSimple, a Bio-Techne brand, has launched the innovative Maurice™ Turbo CE-SDS cartridge. As the name suggests, Turbo enables high speed and high resolution analysis of protein size and purity on Maurice, the flagship capillary electrophoresis (CE) instrument of the iCE family. By providing protein purity results... Read more

Illumina Invests in £30M Venture Fund to Advance Breakthroughs in Human Health

Jun 28, 2022 Investment from LifeArc, Illumina, and Illumina Ventures will fund genomics startups for Illumina Accelerator Cambridge graduates SAN DIEGO, June 28, 2022 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced its participation in Time Boost Capital I LP, a £30 million genomics venture fund dedicated to... Read more

PerkinElmer Introduces New NGS Library Preparation Kits to Accelerate Research and Improve User Experience

Novel updates designed to yield better scientific outcomes and ease of use WHAT: PerkinElmer Inc., a global leader committed to innovating for a healthier world, today announced three new research use only (RUO) library preparation kits: NEXTFLEX® Small RNA-Seq Kit v4, NEXTFLEX® Rapid XP V2 DNA-Seq Kit and PG-Seq™ Rapid Kit v2. HOW: The NEXTFLEX... Read more

Illumina Launches Research Test Codeveloped with Merck to Unlock Deeper Insights into the Tumor Genome

Jun 22, 2022 New assay brings  validated HRD technology from Myriad Genetics to the Illumina TruSight™ Oncology 500, a single, comprehensive pan-cancer test to identify key variants critical for cancer development and progression SAN DIEGO, June 22, 2022 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the launch of a research... Read more

Bio-Techne to acquire single-cell sorting platform provider Namocel

JUNE 22, 2022 MINNEAPOLIS and MOUNTAIN VIEW, Mo., June 22, 2022 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced it has reached an agreement to acquire Namocell, Inc. Bio-Techne anticipates the acquisition to close in the first quarter of its... Read more

Danaher Schedules Second Quarter 2022 Earnings Conference Call

WASHINGTON, June 21, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2022 on Thursday, July 21, 2022 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section of... Read more